J&J Talc MDL: ~$9B Mass Tort

The largest active US mass tort: roughly 68,400 federal claims that J&J’s talc-based baby powder causes ovarian cancer and mesothelioma, back in the tort system after courts rejected the company’s third ‘Texas Two-Step’ bankruptcy and its ~$9B settlement plan.

LATEST DEVELOPMENT · JUL 2026

The MDL reached 68,435 pending cases in July 2026, the largest active federal MDL, as court-ordered mediation continues and the first federal bellwether (Carter Judkins) tracks toward trial later in 2026. J&J says it does not currently intend to offer a global settlement.

PREDICTED OUTCOME

AI-GENERATED · METHODOLOGY →

Settlement ~68% likely HORIZON: framework by 2028, payments later CONFIDENCE: MEDIUM

The most likely end is a negotiated aggregate resolution of the ovarian claims, roughly 68 percent, with a framework emerging between late 2027 and 2029 after the first federal bellwethers are tried. The single strongest driver is Judge Shipp’s coming Daubert ruling: a former MDL judge sitting as special master has already recommended in a 658-page report that plaintiffs’ general-causation experts be admitted, and adoption of that recommendation removes J&J’s last structural exit now that the Texas Two-Step is dead and unappealed. Once tens of thousands of cases become triable and verdicts like the $1.56 billion Craft award start accumulating, the arithmetic of trying 68,400 claims one at a time forces a price, and J&J’s cash generation lets it pay through a long-dated schedule rather than face repeated punitive awards. Expect the number to exceed the withdrawn $9 billion plan, realistically $12 billion to $22 billion in nominal value across ovarian and mesothelioma inventories, funded over 15 to 25 years, likely paired with a claims-administration structure and possibly a consensual Chapter 11 or a Rule 23 settlement class to bind future claimants. J&J’s public stance that it does not intend a global settlement is negotiating posture, not a forecast, and the ongoing court-ordered mediation plus the Kenvue-related indemnity overhang cut the other way. The leading alternative, at roughly 20 percent, is that Shipp rejects the special master’s recommendation in whole or substantial part and excludes the ovarian causation experts, which would gut the MDL, push resolution values down toward a few billion dollars, and let J&J litigate the remaining state-court mesothelioma cases individually. A pure defense victory on the merits across the board, or a fourth bankruptcy attempt succeeding, is unlikely at under 10 percent combined.

Special master recommends admitting plaintiffs’ causation experts · Texas Two-Step exit foreclosed after unappealed 2025 rejection · 68,400 claims plus billion-dollar verdict risk force pricing · Court-ordered mediation running alongside first federal bellwether · J&J cash flow supports long-dated payment structure

Generated by claude-opus-5 on Aug 4, 2026, from this case’s record only. It stands until a major development changes the record. Not legal or investment advice. How predictions are made →

BACKGROUND

Plaintiffs allege that Johnson’s Baby Powder and Shower to Shower were contaminated with asbestos and cause ovarian cancer and mesothelioma, and that J&J concealed the risk for decades. Federal ovarian cancer cases were consolidated as MDL 2738 in New Jersey in October 2016. State juries delivered headline verdicts, most famously $4.69B to 22 women in Ingham (2018), cut to $2.12B and left standing by the Supreme Court in 2021, and J&J pulled talc-based powder from North America in 2020 and worldwide by 2023. J&J then tried three times to resolve the litigation through the ‘Texas Two-Step’: subsidiary LTL Management’s 2021 and 2023 Chapter 11 filings were dismissed for lack of financial distress, and Red River Talc’s third filing, carrying a roughly $9B plan for 90,000+ ovarian claims, was rejected on 31 March 2025 by Judge Christopher Lopez over solicitation and voting defects. J&J declined to appeal, withdrew the offer, and says it will litigate every case.

The MDL has fully reactivated and keeps growing: 68,435 pending cases as of July 2026 (up 406 in a month), the largest active MDL in the federal system. In January 2026, court-appointed special master Freda Wolfson, the MDL’s former presiding judge, issued a 658-page report on renewed Daubert motions recommending that plaintiffs’ general-causation experts be allowed to testify that genital talc use is associated with ovarian cancer. J&J’s objections are before Judge Michael Shipp. Trial results swing wildly, a Baltimore jury awarded $1.56B to a single mesothelioma plaintiff in December 2025 while J&J has won defense verdicts elsewhere, and court-ordered mediation continues alongside preparation of the first federal bellwether, with J&J maintaining it does not currently intend a global settlement.

TIMELINE

JAN 2026PROCEDURAL

Special master recommends admitting plaintiffs’ causation experts

Retired Judge Freda Wolfson’s 658-page report found plaintiffs’ experts reliably showed a statistically significant association between genital talc use and ovarian cancer. J&J’s objections are before Judge Shipp.

Court-Appointed Expert’s Report Threatens J&J Talc Defense
DEC 22, 2025JUDGMENT

Baltimore jury awards $1.56B in Craft mesothelioma case

About $60M compensatory plus $1.5B punitive damages ($1B against J&J, $500M against Pecos River Talc), the largest single-plaintiff talc verdict. J&J is appealing.

J&J Talc Jury Awards $1.56 Billion to Asbestos Cancer Victim
MAR 31, 2025JUDGMENT

Bankruptcy court rejects the plan. J&J returns to the tort system

Judge Christopher Lopez found the solicitation and voting process defective and refused nonconsensual third-party releases. J&J said it would not appeal and withdrew its settlement offer.

What the Collapse of J&J’s Third Talc Bankruptcy Means
SEP 20, 2024OTHER

Red River Talc files the third bankruptcy with a ~$9B plan

The prepackaged Texas Chapter 11 claimed support from over 75% of some 90,000+ ovarian claimants.
JAN 30, 2023JUDGMENT

Third Circuit dismisses the first talc bankruptcy

The court held LTL was not in financial distress. A second LTL filing with an $8.9B proposal was dismissed in July 2023 on the same ground.
OCT 14, 2021OTHER

LTL Management files the first ‘Texas Two-Step’ bankruptcy

J&J moved its talc liabilities into a new subsidiary via a Texas divisional merger and put it into Chapter 11 to force a global resolution.
JUL 12, 2018JUDGMENT

Ingham jury awards $4.69B to 22 women

The St. Louis verdict was later reduced to $2.12B on appeal. The US Supreme Court declined review in June 2021.
OCT 4, 2016PROCEDURAL

JPML consolidates federal talc claims as MDL 2738 in New Jersey